MorphoSys ADR earnings beat by 8.84, revenue topped estimates

Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
MorphoSys ADR earnings beat by 8.84, revenue topped estimates

Read at investing.com
Investing News at Macroaxis
  

MorphoSys Fundamental Analysis

We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

MorphoSys is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

MorphoSys AG ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.

Peers

MorphoSys Related Equities

NVCTNuvectis Pharma   3.98   
0%
63.0%
KRONKronos Bio   1.06   
0%
16.0%
IPSCCentury Therapeutics   0.99   
0%
15.0%
CGEMCullinan Oncology   0.83   
0%
13.0%
PCVXVaxcyte   0.62   
0%
9.0%
LYRALyra Therapeutics   0.53   
0%
8.0%
RLYBRallybio Corp   0.43   
0%
6.0%
MLYSMineralys Therapeutics,   0.00   
0%
0%
EWTXEdgewise Therapeutics   0.00   
0%
0%
PMVPPmv Pharmaceuticals   0.00   
0%
0%
REPLReplimune   0.00   
0%
0%
MRSNMersana Therapeutics   0.00   
0%
0%
GBIOGeneration Bio   0.00   
0%
0%
ELVNEnliven Therapeutics   0.94   
14.0%
0%
IMCRImmunocore Holdings   1.23   
19.0%
0%
ACLXArcellx   1.52   
24.0%
0%
GLUEMonte Rosa   2.22   
35.0%
0%
GOSSGossamer Bio   2.36   
37.0%
0%
CCCCC4 Therapeutics   2.64   
41.0%
0%
IMRXImmuneering Corp   3.86   
61.0%
0%
VTYXVentyx Biosciences   6.30   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in MorphoSys Stock

If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators